FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2932308787> ?p ?o ?g. }

• W2932308787 endingPage "349" @default.
• W2932308787 startingPage "342" @default.
• W2932308787 abstract "BACKDROP Clinicians intuitively recognize that faster time to hemostasis is important in bleeding trauma patients, but these times are rarely reported. METHODS Prospectively collected data from the Pragmatic Randomized Optimal Platelet and Plasma Ratios trial were analyzed. Hemostasis was predefined as no intraoperative bleeding requiring intervention in the surgical field or resolution of contrast blush on interventional radiology (IR). Patients who underwent an emergent (within 90 minutes) operating room (OR) or IR procedure were included. Mixed-effects Poisson regression with robust error variance (controlling for age, Injury Severity Score, treatment arm, injury mechanism, base excess on admission [missing values estimated by multiple imputation], and time to OR/IR as fixed effects and study site as a random effect) with modified Bonferroni corrections tested the hypothesis that decreased time to hemostasis was associated with decreased mortality and decreased incidence of acute kidney injury (AKI), acute respiratory distress syndrome (ARDS), multiple-organ failure (MOF), sepsis, and venous thromboembolism. RESULTS Of 680 enrolled patients, 468 (69%) underwent an emergent procedure. Patients with decreased time to hemostasis were less severely injured, had less deranged base excess on admission, and lower incidence of blunt trauma (all p < 0.05). In 408 (87%) patients in whom hemostasis was achieved, every 15-minute decrease in time to hemostasis was associated with decreased 30-day mortality (RR, 0.97; 95% confidence interval [CI], 0.94–0.99), AKI (RR, 0.97; 95% CI, 0.96–0.98), ARDS (RR, 0.98; 95% CI, 0.97–0.99), MOF (RR, 0.94; 95% CI, 0.91–0.97), and sepsis (RR, 0.98; 95% CI, 0.96–0.99), but not venous thromboembolism (RR, 0.99; 95% CI, 0.96–1.03). CONCLUSION Earlier time to hemostasis was independently associated with decreased incidence of 30-day mortality, AKI, ARDS, MOF, and sepsis in bleeding trauma patients. Time to hemostasis should be considered as an endpoint in trauma studies and as a potential quality indicator. LEVEL OF EVIDENCE Therapeutic/care management, level III." @default.
• W2932308787 created "2019-04-11" @default.
• W2932308787 creator A5021738361 @default.
• W2932308787 creator A5024576216 @default.
• W2932308787 creator A5035870137 @default.
• W2932308787 creator A5037763216 @default.
• W2932308787 creator A5041382422 @default.
• W2932308787 creator A5042251160 @default.
• W2932308787 creator A5045934923 @default.
• W2932308787 creator A5047900529 @default.
• W2932308787 creator A5055279687 @default.
• W2932308787 creator A5056060130 @default.
• W2932308787 creator A5064010012 @default.
• W2932308787 creator A5072490624 @default.
• W2932308787 creator A5081036923 @default.
• W2932308787 creator A5089504452 @default.
• W2932308787 creator A5090675988 @default.
• W2932308787 date "2019-03-19" @default.
• W2932308787 modified "2023-10-12" @default.
• W2932308787 title "Earlier time to hemostasis is associated with decreased mortality and rate of complications: Results from the Pragmatic Randomized Optimal Platelet and Plasma Ratio trial" @default.
• W2932308787 cites W1803784511 @default.
• W2932308787 cites W1967433109 @default.
• W2932308787 cites W2010277284 @default.
• W2932308787 cites W2011356417 @default.
• W2932308787 cites W2022113017 @default.
• W2932308787 cites W2031425506 @default.
• W2932308787 cites W2031798356 @default.
• W2932308787 cites W2057251172 @default.
• W2932308787 cites W2070271048 @default.
• W2932308787 cites W2085326972 @default.
• W2932308787 cites W2092158875 @default.
• W2932308787 cites W2111292680 @default.
• W2932308787 cites W2133226878 @default.
• W2932308787 cites W2140274605 @default.
• W2932308787 cites W2145125317 @default.
• W2932308787 cites W2327686638 @default.
• W2932308787 cites W2333938870 @default.
• W2932308787 cites W2507329566 @default.
• W2932308787 cites W2547475099 @default.
• W2932308787 cites W2555737727 @default.
• W2932308787 cites W2561982390 @default.
• W2932308787 cites W2588986585 @default.
• W2932308787 cites W2607830903 @default.
• W2932308787 cites W2620241325 @default.
• W2932308787 cites W2751404035 @default.
• W2932308787 doi "https://doi.org/10.1097/ta.0000000000002263" @default.
• W2932308787 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6771437" @default.
• W2932308787 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31349348" @default.
• W2932308787 hasPublicationYear "2019" @default.
• W2932308787 type Work @default.
• W2932308787 sameAs 2932308787 @default.
• W2932308787 citedByCount "49" @default.
• W2932308787 countsByYear W29323087872019 @default.
• W2932308787 countsByYear W29323087872020 @default.
• W2932308787 countsByYear W29323087872021 @default.
• W2932308787 countsByYear W29323087872022 @default.
• W2932308787 countsByYear W29323087872023 @default.
• W2932308787 crossrefType "journal-article" @default.
• W2932308787 hasAuthorship W2932308787A5021738361 @default.
• W2932308787 hasAuthorship W2932308787A5024576216 @default.
• W2932308787 hasAuthorship W2932308787A5035870137 @default.
• W2932308787 hasAuthorship W2932308787A5037763216 @default.
• W2932308787 hasAuthorship W2932308787A5041382422 @default.
• W2932308787 hasAuthorship W2932308787A5042251160 @default.
• W2932308787 hasAuthorship W2932308787A5045934923 @default.
• W2932308787 hasAuthorship W2932308787A5047900529 @default.
• W2932308787 hasAuthorship W2932308787A5055279687 @default.
• W2932308787 hasAuthorship W2932308787A5056060130 @default.
• W2932308787 hasAuthorship W2932308787A5064010012 @default.
• W2932308787 hasAuthorship W2932308787A5072490624 @default.
• W2932308787 hasAuthorship W2932308787A5081036923 @default.
• W2932308787 hasAuthorship W2932308787A5089504452 @default.
• W2932308787 hasAuthorship W2932308787A5090675988 @default.
• W2932308787 hasBestOaLocation W29323087872 @default.
• W2932308787 hasConcept C126322002 @default.
• W2932308787 hasConcept C141071460 @default.
• W2932308787 hasConcept C168563851 @default.
• W2932308787 hasConcept C2776348555 @default.
• W2932308787 hasConcept C2777714996 @default.
• W2932308787 hasConcept C2778589496 @default.
• W2932308787 hasConcept C2780472472 @default.
• W2932308787 hasConcept C2908647359 @default.
• W2932308787 hasConcept C42219234 @default.
• W2932308787 hasConcept C44249647 @default.
• W2932308787 hasConcept C71924100 @default.
• W2932308787 hasConcept C73269764 @default.
• W2932308787 hasConcept C82789193 @default.
• W2932308787 hasConcept C99454951 @default.
• W2932308787 hasConceptScore W2932308787C126322002 @default.
• W2932308787 hasConceptScore W2932308787C141071460 @default.
• W2932308787 hasConceptScore W2932308787C168563851 @default.
• W2932308787 hasConceptScore W2932308787C2776348555 @default.
• W2932308787 hasConceptScore W2932308787C2777714996 @default.
• W2932308787 hasConceptScore W2932308787C2778589496 @default.
• W2932308787 hasConceptScore W2932308787C2780472472 @default.
• W2932308787 hasConceptScore W2932308787C2908647359 @default.
• W2932308787 hasConceptScore W2932308787C42219234 @default.
• W2932308787 hasConceptScore W2932308787C44249647 @default.

• next